Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti viral Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel dimethyl phosphonate route for Tenofovir synthesis in patent CN102219805A, offering simplified hydrolysis and significant cost reduction potential.
Patent CN104829599A reveals efficient Ledipasvir synthesis reducing impurities. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Patent CN113461648A discloses a streamlined 2-step synthesis for coumarin-based neuraminidase inhibitors, offering a cost-effective alternative to complex antiviral routes.
Novel one-pot synthesis of piperazinone-hydroxypyridone-5-carboxyl compounds via metal-free catalysis. Enhances supply chain reliability and reduces manufacturing costs for RNA polymerase inhibitors.
Patent CN114133364B reveals a green synthesis for oseltamivir intermediates using biphasic catalysis, offering high purity and reduced manufacturing costs for global supply chains.
Novel patent CN106554371A offers low-cost TNF preparation. Enhances supply chain reliability and purity for pharmaceutical intermediates manufacturing processes globally.
Patent CN101857613A reveals a novel PTC synthesis for anti-influenza rupestonic acid esters, offering cost reduction in API manufacturing and scalable production.
Patent CN111320598A reveals a cost-effective synthesis of 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one, offering superior purity and scalability for antiviral API production.
Novel two-step route for Remdesivir intermediate CN111205294A. Enhanced chiral purity, reduced cost, scalable manufacturing for global pharma supply chains.
Advanced purification method for 2'-fluoro-2'-deoxyuridine via esterification. Delivers >98.5% purity for reliable pharmaceutical intermediate supply chains.
Patent CN1277807C details a novel metal hydride reduction route for carbocyclic nucleoside intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN111484528A reveals a novel halogenation route for TAF intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing supply chains.
Novel 9-step route for 8-chloro-benzothiazepine-1,1-dioxide via CN111518055A. Enhances yield and scalability for RSV drug intermediates.
Patent CN101415719A details efficient L-deoxycytidine production. Offers cost reduction in antiviral manufacturing and reliable supply chain solutions.
Novel Ti-catalyzed radical cyclization for Entecavir intermediates. High purity, scalable process reducing toxic reagents. Ideal for antiviral API manufacturing.
Patent CN107207538A details a high-purity synthesis of Cenicriviroc mesylate. This report analyzes cost reduction in API manufacturing and supply chain reliability for global procurement teams.
Novel total synthesis of houttuynoid hybrid flavonoids via Pd-catalyzed coupling and oxidative cyclization, offering scalable production for antiviral drug development.
Patent CN108299445B reveals a catalyst-free thermal synthesis of 1,5-azaspiro[2,4]heptane. This method offers high purity, cis-selectivity, and reduced manufacturing costs for pharma intermediates.
Patent CN115572317A reveals a novel esterification route for Molnupiravir intermediates, offering superior purity and scalable manufacturing for global supply chains.
Novel triazole-linked betulic acid nucleoside conjugates improve solubility and antitumor activity. Scalable synthesis route available for commercial procurement.